GLP-1 Drugs Show Growing Promise for Afib Control

(MedPage Today) — For patients with obesity and atrial fibrillation (Afib), GLP-1 receptor agonist drugs may be the weight loss approach that best treats their arrhythmia, observational data suggest. People who have come out of catheter ablation…